Long-term renal survival and related risk factors in patients with IgA nephropathy: Results from a cohort of 1155 cases in a Chinese adult population

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1479-1485

  Le, Wei Bo ^a   Liang, Shao Shan ^a   Hu, Yang Lin ^a   Deng, Kang Ping ^a   Bao, Hao ^a   Zeng, Cai Hong ^a   Liu, Zhi Hong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

IgA nephropathy; renal survival; risk factors; time average proteinuria

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERURICEMIA; HYPOPROTEINEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIPID BLOOD LEVEL; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TIME AVERAGE PROTEINURIA; URIC ACID BLOOD LEVEL;

ADULT; CHINA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; HYPERURICEMIA; HYPOPROTEINEMIA; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; PROTEINURIA; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84859358199     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr527     Document Type: Article

References (23)

1. Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 2004; 66: 920-923
2. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196 (Pubitemid 38685989)
3. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005; 18: 503-512 (Pubitemid 41824469)
4. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
5. Goto M, Wakai K, Kawamura T et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 2009; 24: 3068-3074
6. Reich HN, Troyanov S, Scholey JW et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007; 18: 3177-3183 (Pubitemid 350223978)
7. Li PK, Ho KK, Szeto CC et al. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant 2002; 17: 64-69 (Pubitemid 34093011)
8. Radford MG Jr, Donadio JV Jr, Bergstralh EJ et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207 (Pubitemid 127455874)
9. Lv J, Zhang H, Zhou Y et al. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrology (Carlton) 2008; 13: 242-246 (Pubitemid 351341460)
10. Geddes CC, Rauta V, Gronhagen-Riska C et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003; 18: 1541-1548 (Pubitemid 36939626)
11. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research group on progressive renal diseases. Am J Kidney Dis 1997; 29: 526-532 (Pubitemid 27155272)
12. Matthews JN, Altman DG, Campbell MJ et al. Analysis of serial measurements in medical research. BMJ 1990; 300: 230-235 (Pubitemid 20045528)
13. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842 (Pubitemid 27251835)
14. Suzuki K, Honda K, Tanabe K et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003; 63: 2286-2294 (Pubitemid 36605844)
15. Cattran DC, Coppo R, Cook HT et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545
16. Ohno I, Hosoya T, Gomi H et al. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 2001; 87: 333-339 (Pubitemid 32260834)
17. Syrjanen J, Huang XH, Mustonen J et al. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy. Nephron 2000; 86: 115-121
18. Syrjanen J, Mustonen J, Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000; 15: 34-42 (Pubitemid 30037928)
19. Roberts IS, Cook HT, Troyanov S et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009; 76: 546-556
20. Roufosse CA, Cook HT. Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens 2009; 18: 212-219
21. Walsh M, Sar A, Lee D et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 2010; 5: 425-430
22. Tsuboi N, Kawamura T, Koike K et al. Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy. Clin J Am Soc Nephrol 2010; 5: 39-44
23. Kataoka H, Ohara M, Honda K et al. Maximal glomrular diameter as a 10-year prognostic indicator for IgA nephropathy. Nephrol Dial Transplant 2011. http://ndt.oxfordjournals.org/content/early/2011/03/22/ndt.gfr139